Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Colorado, Denver

About this trial

The primary objectives of this study are to determine whether exercise training is an effective strategy for treatment of Long COVID and characterize the cardiorespiratory and autonomic physiology in these patients to precisely characterize mechanisms contributing to this syndrome.

Eligibility criteria

Qualifiers

Adults ≥18 years with documented history of COVID-19 infection and symptoms consistent with Long COVID lasting >12 weeks after diagnosis.

Disqualifiers

History of cardiovascular/pulmonary disease prior to infection

COVID-related myocardial injury such as evidence of myocarditis

Deep vein thrombosis/pulmonary embolism following COVID-19 infection

Exercise intolerance resulting from conditions that are not related to cardiorespiratory or autonomic factors (e.g. osteoarthritis or other musculoskeletal diseases);

Trial design

Treatments tested in this trial

  • Exercise

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators